---
figid: PMC10523227__WJD-14-1349-g003
pmcid: PMC10523227
image_filename: WJD-14-1349-g003.jpg
figure_link: /pmc/articles/PMC10523227/figure/F3/
number: Figure 3
figure_title: ''
caption: 'Genipin protects human retinal microvascular endothelial cells from high
  glucose damage with regard to energy metabolism, oxidative stress, and inflammatory
  injury in vitro. A: ATP levels among normal glucose, high glucose, and genipin-treated
  human retinal microvascular endothelial cells (hRMECs); B-D: Reactive oxygen species,
  mitochondrial membrane potential, and 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-d-glucose
  levels in hRMECs treated with high glucose and genipin; E-L: Western blot and immunofluorescence
  to measure the expression of inflammatory factors expression. IL: Interleukin; TNF:
  Tumor necrosis factor-alpha; NLRP3: Nucleotide-binding domain, leucine-rich-containing
  family, pyrin domain-containing 3; VEGF: Vascular endothelial growth factor; ROS:
  Reactive oxygen species; MMP: Mitochondrial membrane potential; 2-NBDG: 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)
  amino]-2-deoxy-d-glucose; hRMECs: Human retinal microvascular endothelial cells.
  NG: 5 mmol/L glucose containing ECM-treated hRMECs group; HG: 30 mmol/L glucose
  containing ECM-treated hRMECs group; GG: 0.4 Î¼M genipin + 30 mmol/L glucose containing
  ECM-treated hRMECs.'
article_title: Genipin relieves diabetic retinopathy by down-regulation of advanced
  glycation end products via the mitochondrial metabolism related signaling pathway.
citation: Ke-Xin Sun, et al. World J Diabetes. 2023 Sep 15;14(9):1349-1368.
year: '2023'

doi: 10.4239/wjd.v14.i9.1349
journal_title: World Journal of Diabetes
journal_nlm_ta: World J Diabetes
publisher_name: Baishideng Publishing Group Inc

keywords:
- Genipin
- Human retinal microvascular endothelial cells
- Angiogenesis
- Vascularization
- Secretogranin III
- Diabetic retinopathy

---
